Ethical, legal and social issues in maintence of Biobanks
Ethical issues are commonly present in many aspects of Biobanking. The fact that Biobanks deal with human samples, invading an individual autonomy or limiting self-control, provokes a number of ethical issues. Who is actually competent to give informed consent and donate a sample? When individuals donate part of their body to a biobank, how is that human sample processed? Who is the owner of the sample? Who should decide how it should be used? Who has the right to know individual results of research? These and many more ethical dilemmas exist in the ethical framework of biobanks. With the recent rapid developments in biobanking, all of these issues are magnified with plenty of further new questions continuously arising. Ethical framework has been the most controversial issue in the domain of biobanking. Thus, it is not surprising that there is a substantial literature focusing on ethical dilemmas in biobanking, such as informed consent, privacy, protection, and returning of results to participants. For many years, researchers at CRB have provided constructive advice on how to deal with ethical aspects of research using human tissue material and personal data. For more than 80 years tissue has been derived from human bodies, stored, distributed and used for therapeutic, educational, forensic and research purposes as part of healthcare routine in most western countries.
American Society for Bioethics and Humanities Houston, USA, Association of Bioethics World Congress Edinburgh, UK, Oxford Global Health and Bioethics International Conference Oxford shire, UK, CFP: Global Forum on Bioethics in Research Foundation Merieux, France, Hands On Biobanks 2016 conference Vienna, Austria, Global Biobanking London, UK, The Biomarker Conference Orlando, Florida – USA, ART World Congress Symposium on Safe and Efficient IVF New York City, United States, VIII International Postharvest Symposium: Enhancing Supply Chain and Consumer Benefits - Ethical and Technological Issues Cartagena, Murcia, Spain.
According to estimates from the World Bank, global healthcare spending increased at a CAGR of 6.97% from 2003 to 2013, from USD 3,786 Billion in 2003 to USD 7,427 Billion in 2013. In this period, public healthcare spending increased at a CAGR of 7.28%, from USD 2,198 Billion in 2003 to USD 4,440 Billion in 2013. This high growth rate, along with the substantial size of healthcare spending, will act as an important driver for biobanks, hospitals and gene banks, which are the major end-user segments of the biopreservation media & equipment market.
- Ownership, Property Rights and Commercialization in Relation to Biobanking
- Ethical considerations surrounding biobanking and biorepository operation.
- Legal and Ethical Framework For Collaborative Biobanking Across Europe
- Factors Influencing Biobanks Prices
- Ethical issues & future use of samples
Related Conference of Ethical, legal and social issues in maintence of Biobanks
19th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
17th International Conference on Human Genomics and Genomic Medicine
Ethical, legal and social issues in maintence of Biobanks Conference Speakers
Recommended Sessions
- Biobanking Informatics
- Biorepository & Biospecimen
- Cryopreservation Methods
- Data Enrichment in Biobanks
- Ethical, legal and social issues in maintence of Biobanks
- Fertility biobanks
- Frontiers in Bioengineering and Biomaterials
- Germplasm Bank
- Next Generation Biobanking
- Quality Management Systems for Biobanking
- Stemcell Banking
- Tissue engineering
- Vitrification
Related Journals
Are you interested in
- 3D Bio-Printing and Organ Printing - Stemgen 2024 (UK)
- 3D bioprinting using Stem Cells - Stemgen 2024 (UK)
- Advanced Gene Therapeutics - WORLD CELL THERAPY 2024 (UK)
- Advances in Cell Therapy Research - REGENERATIVE MED MEET 2024 (UK)
- Applications of Stem Cells - Stemgen 2024 (UK)
- Applications of Tissue engineering & Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Bio Banking - Stemgen 2024 (UK)
- Bio Banking Stem cell - Stem Cell 2024 (Ireland)
- Bioengineering Therapeutics - WORLD CELL THERAPY 2024 (UK)
- Bioinformatics, Machine learning and Statistical methods - HUMAN GENETICS MEET 2024 (France)
- Biologic Scaffolds for Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Biomaterials & Bioengineering - REGENERATIVE MED MEET 2024 (UK)
- Bone Marrow Transplantation - Stem Cell 2024 (Ireland)
- Bone Marrow Transplantation - Stemgen 2024 (UK)
- Cancer Stem Cell and Oncology - Stemgen 2024 (UK)
- Cancer Therapies - WORLD CELL THERAPY 2024 (UK)
- Cancer, Cardiovascular Diseases and Genetics - HUMAN GENETICS MEET 2024 (France)
- Cell and Gene Therapy - Stemgen 2024 (UK)
- Cell Culture and Bio processing - WORLD CELL THERAPY 2024 (UK)
- Cell Science and Stem Cell Research - WORLD CELL THERAPY 2024 (UK)
- Cell Therapy and Regenerative Medicine Market - REGENERATIVE MED MEET 2024 (UK)
- Cell Therapy in Pulmonology - WORLD CELL THERAPY 2024 (UK)
- Cellular Therapies - WORLD CELL THERAPY 2024 (UK)
- Clinical Genetics and Novel Therapies of Genetic Diseases - HUMAN GENETICS MEET 2024 (France)
- Clinical Methods - Stem Cell 2024 (Ireland)
- Clinical Trials and Research in Cell and Gene Therapies - WORLD CELL THERAPY 2024 (UK)
- Clinical Trials on Cell Therapy and Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Dental Stem Cell - Stemgen 2024 (UK)
- Dental Stem Cells - Stem Cell 2024 (Ireland)
- Diabetes Gene Therapy - WORLD CELL THERAPY 2024 (UK)
- Effect of Aging on Stem Cells - Stemgen 2024 (UK)
- Epigenetics and Gene Regulation - HUMAN GENETICS MEET 2024 (France)
- Evolutionary and Population Genetics - HUMAN GENETICS MEET 2024 (France)
- Functional Genomics and Transcriptomics - HUMAN GENETICS MEET 2024 (France)
- Gene Cloning and Mapping - HUMAN GENETICS MEET 2024 (France)
- Gene Therapy - REGENERATIVE MED MEET 2024 (UK)
- Genetic Vaccines - WORLD CELL THERAPY 2024 (UK)
- HIV Gene Therapy - WORLD CELL THERAPY 2024 (UK)
- Human Gene Therapy - WORLD CELL THERAPY 2024 (UK)
- Human Genetics - HUMAN GENETICS MEET 2024 (France)
- Immunotherapy - REGENERATIVE MED MEET 2024 (UK)
- Immunotherapy - WORLD CELL THERAPY 2024 (UK)
- Models of Regeneration - REGENERATIVE MED MEET 2024 (UK)
- Molecular and Cytogenetics - HUMAN GENETICS MEET 2024 (France)
- Molecular Effects of Genetic Variation - HUMAN GENETICS MEET 2024 (France)
- Molecular Epigenetics - WORLD CELL THERAPY 2024 (UK)
- Molecular Phenotyping and Omics Technologies - HUMAN GENETICS MEET 2024 (France)
- Mutation Detection and Analysis - HUMAN GENETICS MEET 2024 (France)
- Nano-Therapy - WORLD CELL THERAPY 2024 (UK)
- Nanotechnology in Cell Therapy and Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Nanotechnology in Stem Cell - WORLD CELL THERAPY 2024 (UK)
- Neurodegenerative Disease - Stem Cell 2024 (Ireland)
- New Market Trends, R&D on Stem Cells - Stemgen 2024 (UK)
- Novel Approaches guided in Tissue Engineering - REGENERATIVE MED MEET 2024 (UK)
- Novel Stem Cell Therapy - WORLD CELL THERAPY 2024 (UK)
- Orthopedics, Sports Medicine and Regenerative Rehabilitation - REGENERATIVE MED MEET 2024 (UK)
- Pharmacogenomics - HUMAN GENETICS MEET 2024 (France)
- Regeneration and Therapeutics - Stem Cell 2024 (Ireland)
- Regenerative Medicine - Stemgen 2024 (UK)
- Regenerative Medicine in Aging, Dermatology and Plastic Surgery - REGENERATIVE MED MEET 2024 (UK)
- Regenerative Medicine Research - REGENERATIVE MED MEET 2024 (UK)
- Regenerative Medicine research and development - Stemgen 2024 (UK)
- Regenerative Therapy in Osteoarthritis - Stemgen 2024 (UK)
- Research and Development of Stem Cell & Regenerative Drugs - Stem Cell 2024 (Ireland)
- Sickle cell Anaemia Genomics - HUMAN GENETICS MEET 2024 (France)
- Skin Cell Therapy - WORLD CELL THERAPY 2024 (UK)
- Stem Cell and Tissue Engineering - Stemgen 2024 (UK)
- Stem Cell Animal Applications - Stem Cell 2024 (Ireland)
- Stem Cell Apoptosis and Signal Transmission - Stem Cell 2024 (Ireland)
- Stem Cell Embryology - Stem Cell 2024 (Ireland)
- Stem cell engineering - WORLD CELL THERAPY 2024 (UK)
- Stem Cell in Cardiovascular Disease - WORLD CELL THERAPY 2024 (UK)
- Stem Cell in Drug Development - WORLD CELL THERAPY 2024 (UK)
- Stem Cell in Drug Discovery - Stem Cell 2024 (Ireland)
- Stem Cell Therapies - WORLD CELL THERAPY 2024 (UK)
- Stem Cell Therapy - Stemgen 2024 (UK)
- Stem Cell Transplantation - Stem Cell 2024 (Ireland)
- Stem cell Transplantation - HUMAN GENETICS MEET 2024 (France)
- Stem Cell Transplantation to Avoid Cancer - Stemgen 2024 (UK)
- Stem Cells - Stem Cell 2024 (Ireland)
- Stem Cells and Disease Modelling - Stemgen 2024 (UK)
- The use of Stem Cells for COVID-19 Therapy - Stemgen 2024 (UK)
- Theories of Aging in Stem Biology - Stem Cell 2024 (Ireland)
- Tissue Engineering - Stem Cell 2024 (Ireland)
- Tissue Science and Engineering - REGENERATIVE MED MEET 2024 (UK)
- Translational Medicine - HUMAN GENETICS MEET 2024 (France)
- Translational Research in Stem Cell Assessments - Stem Cell 2024 (Ireland)
- Viral gene therapy - WORLD CELL THERAPY 2024 (UK)